Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Sex is a potent modifier of the cardiovascular system

Open access
Leinwand, Leslie A.·2003·Journal of Clinical Investigation

Abstract

Despite the growing number of reports in the literature identifying sex-related differences in cardiac function in both rodents and humans, the underlying mechanisms have yet to be determined. Here, variables of experimental studies such as diet, animal model utilized, and age, in addition to sex hormones and other factors that may play a role in sex-related variations in cardiac responses to various pathophysiological conditions are discussed, suggesting that current approaches used in the study of cardiac disease require reevaluation. There are numerous health problems that are affected by gender. Women are more susceptible than men to depression, osteoporosis, asthma, lung cancer due to smoking, and autoimmune disease (1). Gender effects in disease are complex, however, as exemplified by the observation that while the incidence of melanoma is slightly higher among women than men, mortality from melanoma is higher in men. Not all medical problems show gender dimorphism. For example, males do not differ from females in terms of their responses to infection (1). When it comes to heart disease, generally, of those individuals diagnosed with heart disease, women fare much better than men. Little is known about the basis for this difference in cardiovascular disease. Much focus has been placed on the potential cardioprotective role of estrogen. However, the recent finding that estrogen replacement in postmenopausal women actually increased heart disease has challenged this view (2). Deriving a coherent view of potential players in sex-dependent differences in the heart requires analysis of both the clinical literature and the literature on sex-dependent differences in the cardiovascular system of laboratory animals. There is a major limiting factor in comparing rodent laboratory studies: the vast majority have been carried out on males only. However, this limitation appears to be changing. In the past year, a number of studies have appeared in which both males and females have been analyzed. An article in a recent issue of the JCI by O’Connell et al. (3) provided a glimpse into what promises to be a new way of thinking about genetic sex. In this report, the authors found that the α1-adrenergic receptors are critical in determining heart size and the ability of the heart to respond to both pathologic and physiologic stimuli, but only in male animals. Intriguingly, this sex-related difference did not disappear following ovariectomy of females. This article will discuss the fact that sex is an extremely potent modifier of the myocardium and will identify which pathways have been implicated in some of these differences. I hope it will become clear that future research should focus on the mechanisms by which both sex and diet can modify cardiovascular phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci19429

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 62

  1. O’Connell, 2003, J. Clin. Invest., 111, 1783, 10.1172/JCI200316100 · DOI
  2. Malcolm, 1993, Pediatrics., 92, 703, 10.1542/peds.92.5.703 · DOI
  3. de Simone, 1995, Hypertension., 26, 979, 10.1161/01.HYP.26.6.979 · DOI · Paper page
  4. Grandi, 1992, Cardiology., 81, 8, 10.1159/000175770 · DOI
  5. 10.1016/S0002-9149(99)00392-6 · DOI
  6. 10.1016/0002-9149(93)90355-G · DOI
  7. Adams, 1999, Circulation., 99, 1816, 10.1161/01.CIR.99.14.1816 · DOI · Paper page
  8. 10.1136/hrt.73.6.548 · DOI
  9. 10.1016/0002-9149(94)90437-5 · DOI · Paper page
  10. Aurigemma, 1995, Cardiology., 86, 310, 10.1159/000176895 · DOI
  11. Kimmelstiel, 1995, Cardiology., 86, 304, 10.1159/000176894 · DOI
  12. 10.1016/S0002-8703(96)90056-3 · DOI
  13. 10.1001/archinte.132.5.689 · doi:10.1001/archinte.132.5.689
  14. Mohan, 2002, Cleve. Clin. J. Med., 69, 481, 10.3949/ccjm.69.6.481 · DOI
  15. Fernandez-Sola, 2002, J. Gend. Specif. Med., 5, 41
  16. 10.1007/BF01906669 · DOI
  17. 10.1007/BF01908140 · doi:10.1007/bf01908140
  18. 10.1111/j.1469-7793.1998.533bh.x · doi:10.1111/j.1469-7793.1998.533bh.x
  19. 10.1172/JCI12083 · DOI · Paper page
  20. Pelzer, 1997, Adv. Exp. Med. Biol., 432, 83, 10.1007/978-1-4615-5385-4_9 · doi:10.1007/978-1-4615-5385-4_9
  21. Grohe, 1994, Circulation., 90, I538
  22. 10.1016/0039-128X(96)00014-1 · DOI
  23. 10.1016/0092-8674(86)90705-1 · DOI · Paper page
  24. 10.1016/S0014-5793(97)01179-4 · DOI · Paper page
  25. Marsh, 1998, Circulation., 98, 256, 10.1161/01.CIR.98.3.256 · DOI · Paper page
  26. Koenig, 1982, Circ. Res., 50, 782, 10.1161/01.RES.50.6.782 · DOI
  27. Morano, 1990, Circ. Res., 66, 1585, 10.1161/01.RES.66.6.1585 · DOI
  28. Malhotra, 1990, Am. J. Physiol., 259, H866
  29. Morris, 1998, Horm. Metab. Res., 30, 84, 10.1055/s-2007-978841 · doi:10.1055/s-2007-978841
  30. Scheuer, 1987, Circ. Res., 61, 12, 10.1161/01.RES.61.1.12 · DOI · Paper page
  31. Schaible, 1984, Circ. Res., 54, 38, 10.1161/01.RES.54.1.38 · DOI · Paper page
  32. Sharkey, 1998, Am. J. Physiol., 275, R1968
  33. Thigpen, 1999, Lab Anim. Sci., 49, 530
  34. 10.1016/S0378-4274(02)00009-7 · DOI
  35. Boettger-Tong, 1998, Environ. Health Perspect., 106, 369, 10.1289/ehp.98106369 · DOI
  36. Day, 2002, J. Nutr., 132, 2419S, 10.1093/jn/132.8.2419S · DOI · Paper page
  37. Barkhem, 1998, Mol. Pharmacol., 54, 105, 10.1124/mol.54.1.105 · DOI · Paper page
  38. 10.1210/en.139.10.4252 · DOI · Paper page
  39. Chinni, 2003, Int. J. Mol. Med., 12, 29
  40. 10.1074/jbc.M200347200 · DOI · Paper page
  41. 10.1128/MCB.22.8.2799-2809.2002 · DOI · Paper page
  42. Martin, 2001, Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R553, 10.1152/ajpregu.2001.281.2.R553 · DOI
  43. 10.1016/S0899-9007(02)00744-X · DOI
  44. Zhai, 2001, Am. J. Physiol. Heart Circ. Physiol., 281, H1223, 10.1152/ajpheart.2001.281.3.H1223 · DOI
  45. Rivas, 2002, J. Nutr., 132, 1900, 10.1093/jn/132.7.1900 · DOI · Paper page
  46. Washburn, 1999, Menopause., 6, 7, 10.1097/00042192-199906010-00004 · DOI · Paper page
  47. 10.1016/S0735-1097(99)00165-5 · DOI · Paper page
  48. Tamura, 1999, Hypertension., 33, 676, 10.1161/01.HYP.33.2.676 · DOI
  49. Wallen, 2000, Hypertension., 36, 774, 10.1161/01.HYP.36.5.774 · DOI
  50. Freshour, 2002, Am. J. Physiol. Heart Circ. Physiol., 283, H1997, 10.1152/ajpheart.01054.2001 · DOI
  51. Miyata, 2000, Circ. Res., 86, 386, 10.1161/01.RES.86.4.386 · DOI · Paper page
  52. 10.1161/hh1701.095644 · DOI · Paper page
  53. 10.1016/S0008-6363(01)00387-X · DOI
  54. Freeman, 2001, Am. J. Physiol. Heart Circ. Physiol., 280, 151, 10.1152/ajpheart.2001.280.1.H151 · DOI
  55. 10.1172/JCI6067 · DOI · Paper page
  56. 10.1074/jbc.M102403200 · DOI
  57. 10.1016/S0008-6363(02)00772-1 · DOI
  58. 10.1016/S1095-6433(02)00347-1 · doi:10.1016/s1095-6433(02)00347-1
  59. Janczewski, 2003, Am. J. Physiol. Heart Circ. Physiol., 284, H960, 10.1152/ajpheart.0718.2001 · DOI
  60. Nohammer, 2003, Lab Invest., 83, 259, 10.1097/01.LAB.0000053916.61772.CA · DOI
  61. 10.1016/S0008-6363(02)00663-6 · DOI
  62. 10.1016/S0008-6363(01)00528-4 · DOI

Cited by

See all 190

Metadata

Authors
Leinwand, L. A.
Venue
Journal of Clinical Investigation
Published
2003-08-01
Volume
112
Issue
3
Pages
302-307
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2038944991
Cited by
190
References
1
FWCI
11.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex is a potent modifier of the cardiovascular system. https://app.cochat.ai/papers/10.1172/jci19429
The paper
Leinwand, L. A. (2003). Sex is a potent modifier of the cardiovascular system. Journal of Clinical Investigation. https://doi.org/10.1172/jci19429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.